Kenneth L. Savage, MD

"Our entire staff understands that each of our patients is unique. Our dedication to meet their specific needs and provide the utmost quality of care is what sets us apart. We truly are proud of our recognition as The Cardiology Center with a Heart."


Board Certification:

  • American Board of Internal Medicine, Board Certification in Cardiovascular Disease
  • American Board of Internal Medicine, Board Certification in Internal Medicine
  • National Board of Medical Examiners, Parts I, II and III.

Society Memberships:

  • Member, Florida Medical Association
  • Member, Citrus County Medical Society


  • Founder, Citrus Cardiology Consultants

Research Experience:

  • Sub-Investigator - The Effect of LDL-Cholesterol Lowering Beyond Currently Recommended Minimum Targets on Coronary Heart Disease (CHD) Recurrence in Patients with Pre-Existing CHD, The TNT Trial. 981-117/258-102 Parke Davis and Pfizer, Inc.
  • Sub-Investigator - The Diabetic CHF Trial: A 6 Month, Double Blind, Placebo Controlled, Multicenter Study of Troglitazone (CI-991) in Patients with Type II Diabetes and Congestive Heart Failure. Parke Davis Pharmaceuticals.
  • Sub-Investigator - The ALIVE Trial: A Double Blind, Placebo Controlled, Parallel Design Study to Determine the Effect of 75 or 100 mg of Orally Administered Azimilide Dyhydrochloride versus Placebo on Survival in Recent Post Myocardial Infarction Patients at Risk of Sudden Death. Proctor & Gamble.
  • Sub-Investigator - OVERTURE: Omapatrillat Versus Enalapril Randomized Trial of Utility in Reducing Events. Bristol Myers Squibb.
  • Sub-Investigator - SPORTIF V - A Phase III, Multicenter, Randomized, Double Blind, Two Arm, Parallel Group Study Comparing the Effects of Melagatran vs. a Dose-Adjusted Vitamin K Antagonist (comparator). AstraZeneca.
  • Principal-Investigator - PROVE IT-TIMI 22: Pravastatin Or Atorvastatin Evaluation and Infection Therapy. Bristol Myers Squibb.
  • Sub-Investigator - SAFE: Silent Atrial Fibrillation Detection with Stored EGMs. Guidant.
  • Principal Investigator - IMPACT: The Impact of Medical Subspecialty on Patient Compliance to Treatment. Kos Pharmaceuticals, 2001-present.

Education & Training:

  • Active Member, Citrus Memorial Hospital Staff, Sub-Specialist in Cardiovascular Disease/FL
  • Past Director, CCU Committee, Citrus Memorial Hospital/FL
  • Past Chief of Staff, Citrus Memorial Hospital/FL
  • Past Vice President, Executive Committee, Citrus Memorial Hospital/FL
  • Past Secretary/Treasurer, Executive Committee, Citrus Memorial Hospital/FL
  • Past Member, Executive Committee, Citrus Memorial Hospital/FL
  • Teaching Appointment, Clinical Instructor of Internal Medicine - Medical College of Pennsylvania/PA
  • Cardiology Fellowship - Medical College of Pennsylvania/PA
  • Internship and Residency - Akron City Hospital/Akron, OH
  • Medical Degree - Thomas Jefferson University/Philadelphia, PA
  • Bachelor of Science - University of Notre Dame/IN

Awards & Honors:

  • Magna Cum Laude - University of Notre Dame/IN


  • Florida State Medical License - (active)
  • Pennsylvania State Medical License - (inactive)
  • Ohio State Medical License - (inactive)